Harbin Pharmaceutical Group
pharmaceutical company
Harbin Pharmaceutical Group Co., Ltd. (shortened to HPGC or Hayao) is a Chinese partially state-owned company engaged in the research & development, manufacture, and sale of pharmaceutical products. HPGC medication offerings include traditional Chinese medicine (TCM) and biopharmaceuticals; its main offerings include antibiotics, including amoxicillin and penicillin, and dietary supplements, including zinc gluconate and calcium gluconate.
The company owns both Renmintongtai (人民同泰), a drugstore chain and medical wholesaler for the domestic market, and GNC, a U.S.-based international retailer of supplements and wellness products.
History
In 2007, HPGC obtained approximately 73% and 14% of its total revenue from the sale of Western medicines and TCM preparations, respectively.
In February 2018, HPGC announced its intentions to purchase a 40% stake in GNC Holdings, Inc. for US$300 million, following GNC's filing for Chapter 11 bankruptcy. In September 2020, it wholly acquired the company for US$770 million.
HPGC manufactures and distributes products for GNC China (known as 健安喜; Jiàn'ānxǐ) under a joint venture, GNC (Shanghai) Food Technology Co., Ltd, formed in February 2019.
In February 2022, HPGC was stripped of its National Enterprise Technology Center status, a state designation for enterprises identified as capable of extraordinary technology innovation, by the National Development and Reform Commission after failing to meet the previous year's qualification requirements.
Begin with the source’s own compact description: “Harbin Pharmaceutical Group” is pharmaceutical company. The dossier treats that line as a proposition to test through Harbin, Pharmaceutical and Group, not as a finished interpretation.
Why this record matters
The phrase “pharmaceutical company” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.
Contemporary correspondence, administrative files and participant testimony can test how later narratives organized the event or institution. The source revision retrieved here is dated Jun 15, 2026. The linked authority identifier is Q16241686. None of the 0 selected statements returned an explicit reference. The first chronological checks are 2007, 2018, 2020 and 2019.
Institutional narratives can privilege the records that survived while minimizing voices that were never formally collected. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Compare institutional narratives with records created by participants and affected communities. Dates and formal titles are useful anchors, but not substitutes for context.
- Event chronology
- Institutional context
- Locating named record creators
Contemporary correspondence, government or organizational records, oral histories and cited historical scholarship.
Three-step research path
- Establish the record: confirm the title “Harbin Pharmaceutical Group”, its source revision and the description used here.
- Expand the search: follow Harbin Pharmaceutical Group primary sources, Harbin Pharmaceutical Group archive and Harbin research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Harbin Pharmaceutical Group”?
- Which voices are present, absent or mediated by the institution?
- Who created the surviving record, and for what administrative purpose?
Search terms from this dossier
This entry incorporates text from “Harbin Pharmaceutical Group” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.